Skip to main content
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 1993 Oct;13(5):559–568. doi: 10.1007/BF00711464

Cloning and expression of an anti-nerve growth factor (NGF) antibody for studies using the neuroantibody approach

Francesca Ruberti 1, Andrew Bradbury 1, Antonino Cattaneo 1,
PMCID: PMC11566751  PMID: 8111827

Abstract

  1. The neuroantibody approach, based on the expression of selected monoclonal antibodies by cells of the nervous system, has recently been described (Cattaneo and Neuberger, 1987; Piccioliet al., 1991). In order to apply this experimental strategy to study the role of nerve growth factor (NGF) in the central nervous system (CNS), we exploited the monoclonal antibody (mAb),αD11, which neutralizes very efficiently the biological activity of NGF, bothin vitro andin vivo (Cattaneoet al., 1988).

  2. TheαD11 antibody chains were cloned and expressed in COS cells as rat/human chimaeric proteins. The cloned antibody was shown to display all the properties of the parentalαD11 antibody, including its ability to neutralize NGF biological activity.

  3. This will allow us to engineer the expression of recombinantαD11 antibodies in the CNS, to study the role of NGF in the developing and adult nervous system. This approach can be extended to other neurotrophic factors for which neutralizing monoclonal antibodies are available.

Key words: nerve growth factor, neuroantibodies, cloning of recombinant antibodies

References

  1. Berardi, N., Cattaneo, A., Cellerino, A., Domenici, L., Fagiolini, M., and Maffei, L. (1992). Monoclonal antibodies to NGF affect the postnatal development of the rat geniculocortical system.J. Physiol.452:293P. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bigon, E., Soranzo, C., Minozzi, C., Skaper, S. D., and Callegaro, L. (1990). Large scale purification and immunological characterization of human placental nerve growth factor.Neurochem. Res.151197–1202. [DOI] [PubMed] [Google Scholar]
  3. Biocca, S., Neuberger, M., and Cattaneo, A. (1990). Expression and targeting of intracellular antibodies in mammalian cells.EMBO J.9101–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bocchini, V., and Angeletti, P. U. (1969). The nerve growth factor: purification as a 30,000 molecular weight protein.Proc. Natl. Acad. Sci. USA64787–794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.Cell41521–530. [DOI] [PubMed] [Google Scholar]
  6. Cattaneo, A., and Neuberger, M. S. (1987). Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain.Embo J.62753–2758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cattaneo, A., Biocca, S., Nasi, S., and Calissano, P. (1983). Hidden receptors for NGF in PC12 cells.Eur. J. Biochem.135285–290. [DOI] [PubMed] [Google Scholar]
  8. Cattaneo, A., Rapposelli, B., and Calissano, P. (1983). Three distinct types of monoclonal antibodies after long term immunization of rats with mouse NGF.J. Neurochem.501003–1010. [DOI] [PubMed] [Google Scholar]
  9. Frohman, M. A., Dush, M. K., and Martin, G. (1988). Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer.Proc. Natl. Acad. Sci. USA858998–9002 (1988). [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greene, L. A., and Tischler, A. S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF.Proc. Natl. Acad. Sci. USA732424–2428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kabat, E. A., Wu, T. T., Reid-Miller, M., Perry, H. M., and Gottesman, K. S. (1987).Sequences of Proteins of Immunological Interest. U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC. [Google Scholar]
  12. Levi-Montalcini, R. (1987). The nerve growth factor 30 years later.EMBO J.61145–1154. [DOI] [PubMed] [Google Scholar]
  13. Levi-Montalcini, R., and Angeletti, P. U. (1966). Immunosympathectomy.Pharmacol. Rev.18619–628. [PubMed] [Google Scholar]
  14. Orlandi, R., Gussow, D. H., Jones, P. T., and Winter, G. (1989). Cloning of immunoglobulin variable domains for expression by the polymerase chain reaction.Proc. Natl. Acad. Sci. USA863833–3837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Piccioli, P., Ruberti, F., Biocca, S., Di Luzio, A., Werge, T. M., Bradbury, A., and Cattaneo, A. (1991). Neuroantibodies: Molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system.Proc. Natl. Acad. Sci. USA885611–5615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989).Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
  17. Thoenen, H. (1991). The changing scene of neurotrophic growth factors.Trends Neurosci.14165–170. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES